TY  - GEN
AU  - Raslová,K
AU  - Dobiásová,M
AU  - Nagyová,A
AU  - Fábry,R
AU  - Rauchová,H
AU  - Dusinská,M
TI  - Ciprofibrate treatment in patients with atherogenic lipoprotein phenotype: effects on HDL quality, LDL susceptibility to oxidation and DNA damage
SN  - 0031-6970
PY  - 1999///0326
KW  - Arteriosclerosis
KW  - genetics
KW  - Clofibric Acid
KW  - analogs & derivatives
KW  - DNA Damage
KW  - Female
KW  - Fibric Acids
KW  - Humans
KW  - Hypolipidemic Agents
KW  - therapeutic use
KW  - Kinetics
KW  - Lipoproteins
KW  - Lipoproteins, HDL
KW  - blood
KW  - Lipoproteins, LDL
KW  - Lymphocytes
KW  - drug effects
KW  - Male
KW  - Middle Aged
KW  - Oxidation-Reduction
KW  - Phenotype
N1  - Publication Type: Clinical Trial; Journal Article
UR  - https://doi.org/10.1007/s002280050537
ER  -